e-learning
resources
ERS Research Seminars
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is OSAS a systemic disease?
A. Vgontzas (Hershey, Pa, United States of America)
Source:
Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Number:
2
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Vgontzas (Hershey, Pa, United States of America). Is OSAS a systemic disease?. Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome?
Source: Eur Respir J 2008; 31: 1381-1382
Year: 2008
Is classical OSA the same as OSA in other diseases ?
Source: 5th Sleep and Breathing Conference
Year: 2019
COPD as a systemic disease
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007
Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links?
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Is COPD an autoimmune disease?
Source: Annual Congress 2008 - Scientific year in review: airway remodelling
Year: 2008
Are severe asthma and chronic obstructive pulmonary disease the same disease?
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006
Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
High prevalence of sleep apnea syndrome and systemic hypertension at patients with acromegaly
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010
Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017
Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006
Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
OSA in neurologic disease
Source: Sleep and Breathing Conference 2017
Year: 2017
Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases?
Source: Sleep and Breathing Conference 2017
Year: 2017
Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007
COPD: an autoimmune disease?
Source: Eur Respir J 2011; 38: 484
Year: 2011
Clinical-functional characteristics in patients with combination pathology – chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept